[1]SCHWARTZ R,SCHAFFER AA.The evolution of tumour phylogenetics:principles and practice［J］.Nat Rev Genet,2017,18(4):213-229.
[2]MCGRANAHAN N,SWANTON C.Clonal heterogeneity and tumor evolution:past,present,and the future［J］.Cell,2017,168(4):613-628.
[3]ZHANG J,FUJIMOTO J,ZHANG J,et al.Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing［J］.Science,2014,346(6206):256-259.
[4]BURRELL RA,MCGRANAHAN N,BARTEK J,et al.The causes and consequences of genetic heterogeneity in cancer evolution［J］.Nature,2013,501(7467):338-345.
[5]VENKATASUBRAMANIAN M,CHETAL K,SCHNELL DJ,et al.Resolving single-cell heterogeneity from hundreds of thousands of cells through sequential hybrid clustering and NMF［J］.Bioinformatics,2020,36(12):3773-3780.
[6]WINTERHOFF B,HAMIDI H,WANG C,et al.Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures［J］.Gynecol Oncol,2016,141(1):95-100.
[7]GOVINDAN R,DING L,GRIFFITH M,et al.Genomic landscape of non-small cell lung cancer in smokers and never-smokers［J］.Cell,2012,150(6):1121-1134.
[8]HELLEDAY T,ESHTAD S,NIK-ZAINAL S.Mechanisms underlying mutational signatures in human cancers［J］.Nat Rev Genet,2014,15(9):585-598.
[9]DE BRUIN EC,MCGRANAHAN N,MITTER R,et al.Spatial and temporal diversity in genomic instability processes defines lung cancer evolution［J］.Science,2014,346(6206):251-256.
[10]MAZOR T,PANKOV A,SONG JS,et al.Intratumoral heterogeneity of the epigenome［J］.Cancer Cell,2016,29(4):440-451.
[11]MAZOR T,PANKOV A,JOHNSON BE,et al.DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors［J］.Cancer Cell,2015,28(3):307-317.
[12]ARYEE MJ,LIU W,ENGELMANN JC,et al.DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases［J］.Sci Transl Med,2013,5(169):169.
[13]HAO JJ,LIN DC,DINH HQ,et al.Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma［J］.Nat Genet,2016,48(12):1500-1507.
[14]HINOHARA K,POLYAK K.Intratumoral heterogeneity:more than just mutations［J］.Trends Cell Biol,2019,29(7):569-579.
[15]FEINBERG AP.The key role of epigenetics in human disease prevention and mitigation［J］.N Engl J Med,2018,378(14):1323-1334.
[16]DESHWAR AG,VEMBU S,YUNG CK,et al.Phylo WGS:reconstructing subclonal composition and evolution from whole-genome sequencing of tumors［J］.Genome Biol,2015,16(7):35-48.
[17]ISHAQUE N,ABBA ML,HAUSER C,et al.Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer［J］.Nat Commun,2018,9(1):4782.
[18]SWANTON C.Cancer evolution constrained by mutation order［J］.N Engl J Med,2015,372(7):661-663.
[19]GAO R,DAVIS A,MCDONALD TO,et al.Punctuated copy number evolution and clonal stasis in triple-negative breast cancer［J］.Nat Genet,2016,48(10):1119-1130.
[20]WANG Y,NAVIN NE.Advances and applications of single-cell sequencing technologies［J］.Mol Cell,2015,58(4):598-609.
[21]EL-KEBIR M,OESPER L,ACHESON-FIELD H,et al.Reconstruction of clonal trees and tumor composition from multi-sample sequencing data［J］.Bioinformatics,2015,31(12):i62-i70.
[22]ROTH A,MCPHERSON A,LAKS E,et al.Clonal genotype and population structure inference from single-cell tumor sequencing［J］.Nat Methods,2016,13(7):573-576.
[23]BOGUSZ M,WHELAN S.Phylogenetic tree estimation with and without alignment:new distance methods and benchmarking［J］.Syst Biol,2017,66(2):218-231.
[24]DAVIS A,GAO R,NAVIN N.Tumor evolution:Linear,branching,neutral or punctuated［J］.Biochim Biophys Acta Rev Cancer,2017,1867(2):151-161.
[25]ZIOGAS DE,GLANTZOUNIS G,LIAKAKOS T,et al.Targeting dynamics of subclones of GI,liver and pancreatic cancers［J］.Expert Rev Gastroenterol Hepatol,2016,10(7):773-776.
[26]LING S,HU Z,YANG Z,et al.Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution［J］.Proc Natl Acad Sci USA,2015,112(47):6496-6505.
[27]BASHASHATI A,HA G,TONE A,et al.Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling［J］.J Pathol,2013,231(1):21-34.
[28]BOUTROS PC,FRASER M,HARDING NJ,et al.Spatial genomic heterogeneity within localized,multifocal prostate cancer［J］.Nat Genet,2015,47(7):736-745.
[29]SHAH SP,ROTH A,GOYA R,et al.The clonal and mutational evolution spectrum of primary triple-negative breast cancers［J］.Nature,2012,486(7403):395-399.
[30]TURAJLIC S,SWANTON C.Metastasis as an evolutionary process［J］.Science,2016,352(6282):169-175.
[31]GERLINGER M,ROWAN AJ,HORSWELL S,et al.Intratumor heterogeneity and branched evolution revealed by multiregion sequencing［J］.N Engl J Med,2012,366(10):883-892.
[32]ROZENBLATT-ROSEN O,REGEV A,OBERDOERFFER P,et al.The human tumor atlas network:charting tumor transitions across space and time at single-cell resolution［J］.Cell,2020,181(2):236-249.
[33]CLEARY AS,LEONARD TL,GESTL SA,et al.Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers［J］.Nature,2014,508(7494):113-117.
[34]SOTTORIVA A,KANG H,MA Z,et al.A big bang model of human colorectal tumor growth［J］.Nat Genet,2015,47(3):209-216.
[35]BACA SC,PRANDI D,LAWRENCE MS,et al.Punctuated evolution of prostate cancer genomes［J］.Cell,2013,153(3):666-677.
[36]CLATOT F.Review ctDNA and breast cancer［J］.Recent Results Cancer Res,2020,215:231-252.
[37]KHAN KH,CUNNINGHAM D,WERNER B,et al.Longitudinal liquid biopsy and mathematical modeling of clonal evolution forecast time to treatment failure in the PROSPECT-C phase Ⅱ colorectal cancer clinical trial［J］.Cancer Discov,2018,8(10):1270-1285.
[38]O' LEARY B,HREBIEN S,MORDEN JP,et al.Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer［J］.Nat Commun,2018,9(1):896.
[39]MURTAZA M,DAWSON SJ,POGREBNIAK K,et al.Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer［J］.Nat Commun,2015,6:8760.
[40]ABBOSH C,BIRKBAK NJ,WILSON GA,et al.Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution［J］.Nature,2017,545(7655):446-451.
[41]PAPADOPOULOS N.Pathophysiology of ctDNA release into the circulation and its characteristics:what is important for clinical applications［J］.Recent Results Cancer Res,2020,215:163-180.
[42]EIREW P,STEIF A,KHATTRA J,et al.Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution［J］.Nature,2015,518(7539):422-426.